Pandameds.Com Editorial Team
The Pandameds.Com Editorial Team is dedicated to delivering accurate, transparent and trustworthy health information to help U.S. customers access safe, affordable weight loss medications from Canada. Our team of experienced medical writers, pharmacists and industry professionals ensures every article and product page is thoroughly fact checked, clearly written & updated to reflect the latest clinical guidance.
Each piece of content undergoes a stringent editorial process referencing trusted medical sources such as FDA, Health Canada, PubMed and Mayo Clinic. While we do not provide individual medical advice, our mission is to empower readers with reliable knowledge about medications like Ozempic, Saxenda, Mounjaro, Zepbound, Wegovy and Rybelsus, focused exclusively on their role in medical weight management.
Pandameds.Com helps our readers make informed decisions about their health maintaining a transparent editorial policy and working with certified reviewers
Recent Blog Post
Januvia vs Ozempic: Ozempic (15% Weight Loss), Januvia (2-4lbs) A1c Comparison
When comparing Januvia vs Ozempic, the differences are significant: Ozempic (semaglutide) crushes Januvia (sitagliptin) for weight loss achieving up to 15% body weight reduction compared to Januvia's modest 2 to 4 pounds but Januvia remains substantially cheaper and causes virtually no gastrointestinal side effects. Clinical trials demonstrate Ozempic's superior A1c reduction (1.5-1.8%) compared to Januvia [...]
Medicare Ozempic Coverage 2026: Type 2 Diabetes (Yes), Weight Loss (No) – Complete Guide
Medicare covers Ozempic (semaglutide) for the treatment of type 2 diabetes under Part D prescription drug plans. However, Medicare does not cover Ozempic when prescribed solely for weight loss due to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 which explicitly excludes coverage for weight loss medications. Ozempic is approved for improving blood [...]
Mounjaro Weight Loss Timeline: What to Expect Week by Week
Mounjaro users typically lose 3-5 lbs in their first month, reach 15% body weight reduction by month 12, and can achieve up to 21% loss by week 72-making it one of the fastest-acting GLP-1 weight loss medications available today. According to the SURMOUNT-1 trial published in The New England Journal of Medicine, participants taking tirzepatide [...]
Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs – Diabetes vs Obesity Drugs
Wegovy delivers approximately 15% body weight loss in clinical trials-dramatically outperforming Trulicity’s average weight reduction of about 7–10 lbs (3–5% of body weight). Both are GLP-1 receptor agonists administered as once-weekly injections, yet Wegovy produces roughly 2.5 times greater weight loss results than Trulicity. This makes the choice between these injectable medications heavily dependent on [...]
Contrave vs Ozempic 2026: Weight Loss, Cost & Side Effects Comparison
Contrave and Ozempic are both prescription weight loss medications but they work through very different mechanisms and produce notably different results. Ozempic (semaglutide) typically delivers 10 to 15% body weight loss over 68 weeks while Contrave produces an average of 5 to 8% weight loss over 56 weeks. However, the right choice depends on your [...]
Does Wegovy Cause Headaches? 14% Clinical Rate + Complete Management Guide
Headaches are among the most common side effects of Wegovy. During clinical trials, 14% of adults and 17% of pediatric patients reported headaches while taking Wegovy, compared to 10% and 16% in placebo groups. While these numbers may sound concerning, most headaches are temporary, mild to moderate in severity, and tend to resolve as the [...]
Does Wegovy Make You Tired? 11% Clinical Rate + Complete Management Guide
Yes-Wegovy (semaglutide) can make you tired. According to the drug’s prescribing information, about 11% of adults in clinical trials reported fatigue as a side effect, compared to 5% in the placebo group. While fatigue is among the most common side effects of Wegovy, it is less prevalent than gastrointestinal side effects such as nausea, diarrhea, [...]
Jardiance vs Ozempic 2026: Weight Loss, Diabetes & Cost Comparison
Choosing between Jardiance and Ozempic depends on your individual health needs. Ozempic delivers superior weight loss (12 to 15% body weight vs 2 to 4% with Jardiance) and stronger A1C reduction. Jardiance excels at protecting kidney health and reducing heart failure hospitalizations. Both medications are approved for blood sugar control in type 2 diabetes and [...]
Basaglar vs Ozempic: Insulin vs GLP-1 Comparison 2026
Basaglar and Ozempic represent two fundamentally different approaches to diabetes management. Basaglar - a long-acting insulin, containing insulin glargine, steadily keeps blood sugar levels in check over the course of 24 hours, just by topping up the natural insulin that your body's already producing. Ozempic - a GLP 1 receptor agonist containing semaglutide, however works [...]
Wegovy Constipation: 24% GI Side Effect + Relief Guide – Lasts 47 Days Average
Wegovy constipation affects 24% of users (1 in 4), peaks during the first 16 weeks of treatment, and has a median duration of 47 days caused by approximately 30% slower gut motility from the medication. Wegovy is a GLP-1 receptor agonist that mimics a natural gut hormone. This mechanism supports your weight loss journey but [...]
